VANCOUVER, British Columbia, Oct. 11, 2019 — Isracann Biosciences Inc. (fka Atlas Blockchain Group Inc.) (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company”) is pleased to announce that it has completed its previously announced acquisition (the “Transaction”) of Isracann Holdings Inc. (formerly, Isracann Biosciences Inc.) (“Isracann”). Terms of the Transaction were set out in a
This website contains historical and archived press releases. The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. We are committed to continuous disclosure as a reporting issuer and further details will be filed as and where required on www.sedar.com.